Phillips R E, Solomon T
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford.
Lancet. 1990 Dec 1;336(8727):1355-60. doi: 10.1016/0140-6736(90)92903-u.
Cerebral malaria is a rapidly progressive encephalopathy with up to 50% mortality. A cardinal feature is the massing of red cells containing mature Plasmodium falciparum within the cerebral capillaries. Adhesion of these parasitised red cells to endothelium, an event which may initiate cerebral malaria, is being studied at the molecular level. However, the relevance of these studies to the pathophysiology and treatment of human cerebral malaria is uncertain. Although chloroquine is still widely used to treat falciparum malaria, resistance has spread to most of the endemic zone. Quinine is emerging as the only effective treatment for cerebral malaria, though resistance to this drug threatens to become a problem. Alternative drugs are urgently needed.
脑型疟疾是一种进展迅速的脑病,死亡率高达50%。一个主要特征是脑毛细血管内大量聚集含有成熟恶性疟原虫的红细胞。这些被寄生的红细胞与内皮细胞的黏附可能引发脑型疟疾,目前正在分子水平上对此进行研究。然而,这些研究与人类脑型疟疾的病理生理学和治疗的相关性尚不确定。尽管氯喹仍被广泛用于治疗恶性疟,但耐药性已蔓延至大多数流行地区。奎宁正成为脑型疟疾唯一有效的治疗药物,不过对该药的耐药性也有可能成为问题。迫切需要替代药物。